This increased risk of viral non‐suppression after resuming ART, combined with other adverse outcomes such as slower CD4+ cell count increases [2, 51, 52, 53], faster progression to AIDS [54, 55, 56, 57] and increased mortality [2, 58], indicates a need for further interventions designed to retain people on ART. The gene discussed is CD4; the disease is AIDS.